EUVIMEDOdkrijte EUVIMED
CrossrefInformačná karta

Evaluating the Efficacy of Dialectical and Cognitive Behavioral Therapies in Reducing Impulsive Behaviors

Mehran Rostamzadeh, Abbas Ali Husseini, William Mosier

Journal of Public Health and Primary Care · 2024

DOI: 10.4103/jphpc.jphpc_10_24 ↗
AbstraktBibliografické údaje

Abstrakt

Abstract Background: Dialectical Behavior Therapy (DBT) and Cognitive Behavioral Therapy (CBT) are known to mitigate impulsivity in patients with borderline personality disorder (BPD). Aims and Objectives: This study aims to evaluate their impact on impulsivity in individuals without BPD. Materials and Methods: A non-randomized trial using a convenience sampling method, was conducted with 65 patients exhibiting impulsive behaviors who visited the Amir Kabir Medical Center in Arak between January 20 and March 20, 2023. After excluding those who did not meet the inclusion criteria, 48 participants remained. These participants were divided into three groups: two experimental groups receiving either DBT or CBT, and a control group with no intervention. Both experimental groups underwent 14 sessions of 45 minutes each. Pretest and posttest evaluations were conducted using the Barratt Impulsiveness Scale (BIS), and the data were analyzed using multivariate analysis of covariance. Results: The findings revealed a significant reduction in impulsive behaviors in both experimental groups compared to their pretest scores, with a statistically significant difference between the experimental and control groups. Conclusion: This study demonstrates that the techniques employed can serve as an effective behavioral treatment package for impulsive behaviors in non-BPD patients.

Vedomosti, ktoré zodpovedajú vašej práci.

Od bezplatného začiatku cez osobnú rešerš literatúry až po kompletný Research Suite.

Zobraziť tarify →

Sú zahrnuté všetky plné texty vydavateľov?

Nie. Bibliografické záznamy, abstrakty a plné texty sú odlišné typy obsahu. To, či je plný text dostupný, závisí od zdroja, Open Access a vašich existujúcich licencií. Tarif EUVIMED nenahrádza dodatočné práva vydavateľa.

Zobraziť tarify →